Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma

Cancer Research

Volumn 60, Issue 2, 2000, Pages 309-320

  Livant, Donna L ^a   Brabec, R Kaye ^a   Pienta, Kenneth J ^a   Allen, David L ^a   Kurachi, Kotoku ^a   Markwart, Sonja ^a   Upadhyaya, Ameet ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN;

AFFINITY CHROMATOGRAPHY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASEMENT MEMBRANE; BINDING AFFINITY; CANCER CELL; CANCER INVASION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; METASTASIS INHIBITION; PRIORITY JOURNAL; PROSTATE TUMOR; TUMOR CELL CULTURE; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BASEMENT MEMBRANE; CELL SURVIVAL; CHEMOTAXIS; FIBRONECTINS; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; RATS; RECEPTORS, FIBRONECTIN; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0034650758     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Von Eschenbach, A., Ho, R., Murphy, G. P., Cunningham, M., and Lins, N. American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J. Clin., 47: 261-264, 1997.
2. Carter, H. B., and Coffey, D. S. Prostate cancer: the magnitude of the problem in the United States. In: D. S. Coffey, M. I. Resnick, F. A. Dorr, and J. P. Karr (eds.), A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer, pp. 1-7. New York: Plenum Publishing Corp., 1988.
3. Fournier, G. Treatment of hormone-refractory prostate carcinoma. Eur. Urol., 30 (Suppl. 1): 32-37, 1996.
4. Schulze, H., Isaacs, J. T., and Coffey, D. S. A critical review of the concept of total androgen ablation in the treatment of prostatic cancer. In: G. P. Murphy, S. Khory, R. Kuss, C. Chatelain, and L. Denis (eds.), Prostate Cancer Part A: Research, Endocrine Treatment, and Histopathology: Progress in Clinical and Biological Research, Vol. 243A, pp. 1-19. New York: Wiley-Liss, 1987.
5. Raghaven, D. Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs. Semin. Oncol., 15: 371-389, 1988.
6. Silverberg, E., and Lubera, J. A. Cancer statistics. CA Cancer J. Clin., 38: 107-115, 1988.
7. Pienta, K. J., Naik, H., Akhtar, A., Yamazaki, K., Replogle, T. S., Lehr, J., Donat, T. L., Tait, L., Hotan, V., and Raz, A. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J. Natl. Cancer Inst., 87: 348-353, 1995.
8. Vukanovic, J., and Isaacs, J. T. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Res., 55: 1499-1504, 1995.
9. Dunning, W. F. Prostatic cancer in the rat. Monogr. Natl. Cancer Inst., 12: 351-369, 1963.
10. Isaacs, J. T., Isaacs, W. B., and Feitz, W. F. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate, 9: 261-281, 1986.
11. Pienta, K. J., Murphy, B. C., and Isaacs, W. B. Effect of pentosan, a novel cancer chemotherapeutic agent, on prostate cancer cell growth and motility. Prostate, 20: 233-241, 1992.
12. Mosher, D. F. Physiology of fibronectin. Annu. Rev. Med., 35: 561-575, 1984.
13. Hayman, E. G., Pierschbacher, M., and Engvall, E. Fibronectin. Purification, immunochemical properties, and biological activities. Methods Enzymol., 82: 803-831, 1982.
14. Livant, D. L., Linn, S., Markwart, S., and Shuster, J. Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts. Cancer Res., 55: 5085-5093, 1995.
15. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., and Paulsen, D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer, 21: 274-281, 1978.
16. Peehl, D. M. Culture of human prostatic epithelial cells. In: R. I. Freshney (ed.), Culture of Epithelial Cells, pp. 159-180. New York: Wiley-Liss, 1992.
17. Akiyama, S. K., and Yamada, K. M. The interactions of plasma fibronectin with fibroblastic cells in suspension. J. Biol. Chem., 260: 4492-4500, 1985.
18. Burnette, W. N. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem., 112: 195-203, 1981.
19. Litvinovich, S. V., and Ingham, K. C. Interactions between type III domains in the 110 kDa cell-binding fragment of fibronectin. J. Mol. Biol., 248: 611-626, 1995.
20. Wayner, E. A., Carter, W. G., Piotrowicz, R. S., and Kunicki, T. J. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-Ila. J. Cell Biol., 107: 1881-1891, 1988.
21. Atherton, E., and Sheppard, R. C. Solid Phase Peptide Synthesis: A Practical Approach. Oxford, England: IRL Press, 1989.
22. Mant, C. T., Kondejewski, L. H., Cachia, P. J., Monera, O. D., and Hodges, R. S. Analysis of synthetic peptides by high-performance liquid chromatography. Methods Enzymol., 289: 426-469, 1997.
23. Templeton, N. S., Brown, P. D., Levy, A. T., Margulies, I. M. K., Liotta, L. A., and Stetler-Stevenson, W. G. Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res., 50: 5431-5437, 1990.
24. Postlethwaite, A. E., Snyderman, R., and Kang, A. H. The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J. Exp. Med., 144: 1188-1203, 1976.
25. Flaris, N. A. Characterization of microglia and macrophages in the central nervous system of the rat. GLIA, 7: 34-40, 1993.
26. Male, D. An interferon inducible molecule on brain endothelium which controls lymphocyte adhesion mediated by integrins. Immunology, 84: 453-460, 1995.
27. Tomaselli, K. J., Damsky, C. H., and Reichardt, L. F. Purification and characterization of mammalian integrins expressed by a rat neuronal cell line (PC12): evidence that they function as α/β heterodimeric receptors for laminin and type IV collagen. J. Cell Biol., 107: 1241-1252, 1988.
28. Rossino, P., Gavazzi, I., Timpl, R., Aumailley, M., Abbadini, M., Giancotti, F., Silengo, L., Marchisio, P. C., and Tarone, G. Nerve growth factor induces increased expression of a laminin-binding integrin in rat pheochromocytoma PC12 cells. Exp. Cell Res., 189: 100-108, 1990.
29. Lafarga, M., Berciano, M. T., and Carmo-Fonseca, M. Semithin cryosections as a tool to perform high resolution immunofluorescence and in situ hybridization analysis of nervous tissue: a study in the supraoptic nucleus. J. Neurosci. Methods, 75: 137-145, 1997.
30. Wiltbank, M. C., Gallagher, K. P., Cristensen, A. K., Brabec, R. K., and Keyes, P. L. Physiological and immunocytochemical evidence for a new concept of blood flow regulation in the corpus luteum. Biol. Reprod., 42: 139-149, 1990.
31. Humason, G. L. Animal Tissue Techniques. pp. 34-169. San Francisco, CA: W. H. Freeman and Company, 1972.
32. Amemiya, S. Development of the basal lamina and its role in migration and pattern formation of primary mesenchyme cells in sea urchin embryos. Dev. Growth Differ., 31: 131-145, 1989.
33. Roklin, O. W., and Cohen, M. B. Expression of cellular adhesion molecules on human prostate tumor cell lines. Prostate, 26: 205-212, 1995.
34. Huhtala, P., Humphries, M. J., McCarthy, J. B., Tremble, P. M., Werb, Z., and Damsky, C. H. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol., 129: 867-879, 1995.
35. Hayman, E. G., and Ruoslahti, E. Distribution of fetal bovine serum fibronectin and endogenous rat cell fibronectin in extracellular matrix. J. Cell Biol., 83: 255-259, 1979.
36. Witkowski, C. M., Rabinovitz, I., Nagle, R. B., Affinito, K. D., and Cress, A. E. Characterization of integrin subunits, cellular adhesion and tumorigenicity of four human prostate cell lines. Cancer Res. Clin. Oncol., 119: 637-644, 1993.
37. Akiyama, S. K., Older, K., and Yamada, K. M. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev., 14: 173-189, 1995.
38. Mould, A. P., Askari, J. A., Aota, S. I., Yamada, K. M., Irie, A., Takada, Y., Mardon, H. J., and Humphries, M. J. Defining the topology of integrin α5β1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit. J. Biol. Chem., 272: 17283-17292, 1997.
39. Aota, S., Nomizu, M., and Yamada, K. M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell adhesive function. J. Biol. Chem., 269: 24756-24761, 1994.
40. Reed, G. H. Manganese. An overview of chemical properties. In: V. L. Schramm and F. C. Wedler (eds.), Manganese in Metabolism and Enzyme Function, pp. 313-323. Orlando, FL: Academic Press, Inc., 1986.
41. Foulkes, E. C. Role of metallothionein in epithelial transport and sequestration of cadmium. In: C. D. Klaassen and K. T. Suzuki (eds.). Metallothionein in Biology and Medicine, pp. 171-182. Boca Raton, FL: CRC Press, 1991.
42. Newman, P. J. The biology of PECAM-1. J. Clin. Invest., 100 (Suppl. 11): S25-S29, 1997.
43. Elstein, K. H., and Zucker, R. M. Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations. Exp. Cell Res., 211: 322-331, 1994.
44. Zar, J. H. Two-sample hypotheses. In: Biostatistical Analysis, pp. 138-141. Englewood Cliffs. NJ: Prentice-Hall, Inc., 1984.
45. Mogford, J. E., Davis, G. E., and Neininger, G. A. RGDN peptide interaction with endothelial α5β1 integrin causes sustained endothelin-dependent vasoconstriction of rat skeletal muscle arterioles. J. Clin. Investig., 100: 1647-1653, 1997.
46. Clark, R. A. F. Wound repair. In: R. A. F. Clark (ed.), The Molecular and Cellular Biology of Wound Repair, pp. 12-17. New York: Plenum Publishing Corp., 1996.
47. Kim, J., Yu, W., Kovalski, K., and Ossowski, L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell, 94: 353-362, 1998.
48. Doherty, D. E., Henson, P. M., and Clark, R. A. Fibroncetin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for G5 fragment-induced monocyte lung accumulation. J. Clin. Invest., 86: 1065-1075, 1990.
49. Postlethwaite, A. E., Keski-Oja, J., Bailan, G., and Kang, A. Induction of fibroblast chemotaxis by fibronectin. Location of the chemotactic region to a 140,000 molecular weight nongelatin binding fragment. J. Exp. Med., 153: 494-499, 1981
50. Jungwirth, A., Schally, A. V., Pinski, J., Halmos, G., Groot, K., Armatis, P., and Vadillo-Buenfil, M. Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone. Br. J. Cancer, 75: 1585-1592, 1997.
51. Johansson, S., Landstrom, M., Hellstrand, K., and Henriksson, R. The response of Dunning R3327 prostatic adenocarcinoma to IL-2. histamine and radiation. Br. J. Cancer, 77: 1213-1219, 1998.
52. Pinski, J., Reile, H., Halmos, G., Groot, K., and Schally, A. V. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Cancer Res., 54: 169-174, 1994.
53. Srialovic, G., Bokser, L, Radulovic, S., Korkut, E., and Schally, A. V. Receptors for luteinizing hormone-releasing hormone (LH-RH) in Dunning R-3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LH-RH antagonist SB-75. Endocrinology, 127: 3052-3060, 1990.
54. Pinski, J., Schally, A. V., Yano, T., Szepeshazi, K., Halmos, G., Groot, K., Comaru-Schally, A. M., Radulovic, S., and Nagy, A. Inhibition of growth of experimental prostate cancer in rats by LH-RH analogs linked to cytotoxic radicals. Prostate, 23: 165-178, 1993.
55. de Souza, P. L., Castillo, M., and Myers, C. E. Enhancement of Paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrine. Br. J. Cancer. 75: 1593-1600, 1997.
56. Humphries, M. J., Olden, K., and Yamada, K. M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science (Washington DC), 233: 467-470, 1986.
57. Iwamoto, Y., Robey, F. A., Graf, J., Sasaki, M., Kleinman, H. K., Yamada, Y., and Martin, G. R. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science (Washington DC), 238: 1132-1134, 1987.
58. Saiki, I., Murata, J., Matsuno, K., Ogawa, R., Nishi, N., Tokura, S., and Azuma, I. Anti-metastatic and anti-invasive effects of polymeric Arg-Gly-Asp (RGD) peptide, poly (RGD), and its analogues. Jpn. J. Cancer Res., 81: 660-667, 1990.